As the opioid crisis continues to take lives in big cities and small communities across Canada, a Kingston technology company has developed a rapid testing system to identify the lethal contaminants sometimes present in street drugs.
Spectra Plasmonics’ drug analysis system identifies the unique chemical “fingerprints” of various substances found in a sample and can detect the presence of dangerous contaminants such as fentanyl.
The technology is currently being piloted at a supervised consumption site in Kingston, but company officials say they’re eager to roll out the devices across North America.
OBJ360 (Sponsored)
Adapting to hybrid Work: How IAV Is simplifying office technology with BYOD solutions
You may have heard of BYOB, but have you heard of BYOD? BYOD, also known as “Bring your own device” is becoming a common practice for companies following hybrid work
From world-class to worrisome: The challenges facing Ottawa transit
This has been an incredible year for news. There are many contenders for Ottawa newsmaker of the year: Michael Andlauer’s Senators ownership and a new arena at LeBreton Flats; Tobi
“We want this to be in the hands of everybody whose job it is to save lives in this crisis,” says company co-founder and CEO Malcolm Eade.
Learn more about Spectra Plasmonics by watching the full interview with Eade above.
